{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T18:17:55Z","timestamp":1789669075201,"version":"4.0.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Clinique et Biologique"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.tracli.2017.05.013","type":"journal-article","created":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T02:15:48Z","timestamp":1498184148000},"page":"110-114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Drug-induced hemolytic anemia: Pharmacological aspects"],"prefix":"10.1016","volume":"24","author":[{"given":"D.","family":"Renard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Rosselet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tracli.2017.05.013_bib0085","first-page":"572","article-title":"Caring for Glucose-6-Phosphate Dehydrogenase (G6PD)-Deficient Patients: implications for Pharmacy","volume":"40","author":"Bubp","year":"2015","journal-title":"PT"},{"key":"10.1016\/j.tracli.2017.05.013_bib0090","first-page":"310","article-title":"Hemolytic anemia following rasburicase administration: a review of published reports","volume":"19","author":"Nguyen","year":"2014","journal-title":"J Pediatr Pharmacol Ther"},{"key":"10.1016\/j.tracli.2017.05.013_bib0095","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1526-0968.2003.00127.x","article-title":"Drug-induced thrombotic thrombocytopenic purpura\/hemolytic uremic syndrome: a concise review","volume":"8","author":"Dlott","year":"2004","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.tracli.2017.05.013_bib0100","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1182\/blood-2014-11-611335","article-title":"Drug-induced thrombotic microangiopathy: a systematic review of published reports","volume":"125","author":"Al-Nouri","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2017.05.013_bib0105","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jcf.2010.08.010","article-title":"Antibiotic hypersensitivity in CF: drug-induced life-threatening hemolytic anemia in a pediatric patient","volume":"9","author":"Chavez","year":"2010","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.tracli.2017.05.013_bib0110","doi-asserted-by":"crossref","first-page":"66","DOI":"10.21307\/immunohematology-2019-100","article-title":"Drugs that have been shown to cause drug-induced immune hemolytic anemia or positive direct antiglobulin tests: some interesting findings since 2007","volume":"30","author":"Garratty","year":"2014","journal-title":"Immunohematology"},{"key":"10.1016\/j.tracli.2017.05.013_bib0115","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/j.1537-2995.2009.02544.x","article-title":"Piperacillin-induced immune hemolysis: new cases and review of the literature","volume":"50","author":"Mayer","year":"2010","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2017.05.013_bib0120","article-title":"Piperacillin-induced mild haemolytic anaemia in a 44-year-old patient with cystic fibrosis","volume":"24","author":"Meinus","year":"2016","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.tracli.2017.05.013_bib0125","doi-asserted-by":"crossref","first-page":"216","DOI":"10.24953\/turkjped.2016.02.016","article-title":"Ceftriaxone-induced hemolytic anemia in a child successfully managed with intravenous immunoglobulin","volume":"58","author":"Vehapoglu","year":"2016","journal-title":"Turk J Pediatr"},{"key":"10.1016\/j.tracli.2017.05.013_bib0130","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1159\/000440673","article-title":"Variability of findings in Drug-induced Immune Haemolytic Anaemia: experience over 20 years in a single centre","volume":"42","author":"Mayer","year":"2015","journal-title":"Transfus Med Hemother"},{"key":"10.1016\/j.tracli.2017.05.013_bib0135","doi-asserted-by":"crossref","DOI":"10.1186\/1475-2875-13-398","article-title":"Severe delayed autoimmune haemolytic anemia following artesunate administration in severe malaria: a case report","volume":"13","author":"Raffray","year":"2014","journal-title":"Malar J"},{"key":"10.1016\/j.tracli.2017.05.013_bib0140","doi-asserted-by":"crossref","first-page":"44","DOI":"10.21307\/immunohematology-2019-098","article-title":"Drug-induced immune hemolytic anemia: the last 30 years of change","volume":"30","author":"Arndt","year":"2014","journal-title":"Immunohematology"},{"key":"10.1016\/j.tracli.2017.05.013_bib0145","doi-asserted-by":"crossref","first-page":"80","DOI":"10.21307\/immunohematology-2019-101","article-title":"Diagnostic pitfalls of drug-induced immune hemolytic anemia","volume":"30","author":"Salama","year":"2014","journal-title":"Immunohematology"},{"key":"10.1016\/j.tracli.2017.05.013_bib0150","doi-asserted-by":"crossref","first-page":"85","DOI":"10.21307\/immunohematology-2019-102","article-title":"How we investigate drug-induced immune hemolytic anemia","volume":"30","author":"Leger","year":"2014","journal-title":"Immunohematology"},{"key":"10.1016\/j.tracli.2017.05.013_bib0155","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.tracli.2017.05.013_bib0160","series-title":"Portail d\u2019information-M\u00e9dicaments essentiels et produits de sant\u00e9. Comit\u00e9s pharmaceutiques et th\u00e9rapeutiques\u2013Guide pratique; Annexe 5.3 Algorithme de Naranjo pour l\u2019\u00e9valuation de la causalit\u00e9 d\u2019une r\u00e9action ind\u00e9sirable","author":"Organisation mondiale de la sant\u00e9","year":"2017"}],"container-title":["Transfusion Clinique et Biologique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782017300757?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782017300757?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:36:43Z","timestamp":1761129403000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1246782017300757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S1246782017300757"],"URL":"https:\/\/doi.org\/10.1016\/j.tracli.2017.05.013","relation":{},"ISSN":["1246-7820"],"issn-type":[{"value":"1246-7820","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug-induced hemolytic anemia: Pharmacological aspects","name":"articletitle","label":"Article Title"},{"value":"Transfusion Clinique et Biologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tracli.2017.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}